INT342621

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.09
First Reported 2010
Last Reported 2010
Negated 0
Speculated 0
Reported most in Body
Documents 1
Total Number 2
Disease Relevance 1.53
Pain Relevance 0.57

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

extracellular space (VEGFA, Timp2) growth (VEGFA) extracellular region (VEGFA)
proteinaceous extracellular matrix (VEGFA) nucleus (Timp2) cytoplasm (VEGFA)
VEGFA (Homo sapiens)
Timp2 (Mus musculus)
Pain Link Frequency Relevance Heat
metalloproteinase 16 100.00 Very High Very High Very High
palliative 86 85.04 High High
Disease Link Frequency Relevance Heat
Cancer 72 98.76 Very High Very High Very High
Lifespan 16 89.32 High High
Body Weight 2 87.52 High High
Metastasis 48 86.68 High High
Dislocations 2 84.04 Quite High
Death 2 58.64 Quite High
Hepatocellular Cancer 116 50.00 Quite Low
Residual Neoplasm 6 5.00 Very Low Very Low Very Low
Anaemia 2 5.00 Very Low Very Low Very Low
Thrombocytopenia 2 5.00 Very Low Very Low Very Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
The in situ activities of membrane type 1-matrix metalloproteinase (MT1-MMP), matrix metalloproteinase 2 (MMP2), and protein levels of MMP2, tissue inhibitor of metalloproteinase 2 (TIMP2), vascular endothelial growth factor (VEGF), and endostatin in the grown tumors obtained from the implantation sites were determined.
VEGF Negative_regulation (inhibitor) of TIMP2 associated with cancer and metalloproteinase
1) Confidence 0.09 Published 2010 Journal BMC Cancer Section Body Doc Link PMC2976755 Disease Relevance 0.76 Pain Relevance 0.29
The in situ activities of membrane type 1-matrix metalloproteinase (MT1-MMP), matrix metalloproteinase 2 (MMP2), and protein levels of MMP2, tissue inhibitor of metalloproteinase 2 (TIMP2), vascular endothelial growth factor (VEGF), and endostatin in the grown tumors obtained from the implantation sites were determined.
VEGF Negative_regulation (inhibitor) of metalloproteinase 2 associated with cancer and metalloproteinase
2) Confidence 0.08 Published 2010 Journal BMC Cancer Section Body Doc Link PMC2976755 Disease Relevance 0.76 Pain Relevance 0.29

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox